On ECHEMI
Home > Drugs > Qilu Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd.
  • Founded in:

    1992-08-21
  • Country:

    China China
  • Address:

    No. 317, Xinluo Street, High-tech Zone, Jinan City, Shandong Province
  • Tax NO.:

    91370000614073351Q
  • Registered Funds:

    600 million yuan
  • Website:

  • Email:

Related Drugs
Decitabine
Name Description Content CAS NO. Registered Holders
5-Aza-2'-deoxycytidine

Extract from the above information

More

Extract from the above information

2353-33-5 28
Low molecular weight heparin sodium gel
Low molecular weight heparin sodium
Name Description Content CAS NO. Registered Holders
Low molecular weight heparin sodium

The anticoagulant effect of low molecular weight heparin may increase local vascular permeability and improve local blood circulation, thereby reducing swelling and removing blood stasis.

More

The anticoagulant effect of low molecular weight heparin may increase local vascular permeability and improve local blood circulation, thereby reducing swelling and removing blood stasis.

0
Low molecular weight heparin sodium gel
Low molecular weight heparin sodium
Name Description Content CAS NO. Registered Holders
Low molecular weight heparin sodium

The anticoagulant effect of low molecular weight heparin may increase local vascular permeability and improve local blood circulation, thereby reducing swelling and removing blood stasis.

More

The anticoagulant effect of low molecular weight heparin may increase local vascular permeability and improve local blood circulation, thereby reducing swelling and removing blood stasis.

0
Aprepitant capsules
The main ingredient of this product is aprepitant. Chemical name: 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one. Molecular formula: C23H21F7N4O3. Molecular weight: 534.43
Name Description Content CAS NO. Registered Holders
Aprepitant

It is a selective high-affinity antagonist of the human substance P neurokinin 1 (NK1) receptor that inhibits vomiting induced by cytotoxic chemotherapy drugs such as cisplatin and enhances the antiemetic activity of the 5-HT3 receptor antagonist ondansetron and the glucocorticoid dexamethasone on cisplatin-induced vomiting.

More

It is a selective high-affinity antagonist of the human substance P neurokinin 1 (NK1) receptor that inhibits vomiting induced by cytotoxic chemotherapy drugs such as cisplatin and enhances the antiemetic activity of the 5-HT3 receptor antagonist ondansetron and the glucocorticoid dexamethasone on cisplatin-induced vomiting.

170729-80-3 25
Terbinafine Hydrochloride Tablets
The main ingredient of this product is terbinafine hydrochloride.
Name Description Content CAS NO. Registered Holders
Terbinafine Hydrochloride

Terbinafine hydrochloride is a broad-spectrum antifungal drug of the allylamine class. It can specifically interfere with the early biosynthesis of fungal sterols, selectively inhibit the activity of fungal squalene epoxidase, and hinder the squalene epoxidation reaction in the process of fungal cell membrane formation, thereby achieving the effect of killing or inhibiting fungi.

More

Terbinafine hydrochloride is a broad-spectrum antifungal drug of the allylamine class. It can specifically interfere with the early biosynthesis of fungal sterols, selectively inhibit the activity of fungal squalene epoxidase, and hinder the squalene epoxidation reaction in the process of fungal cell membrane formation, thereby achieving the effect of killing or inhibiting fungi.

78628-80-5 70
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.